Up ahead, we're breaking down the top concerns circling the platform, serving up expert-backed tips for keeping the risks in ...

AstraZeneca (NASDAQ:AZN) announced plans to directly list its shares in the U.S., while confirming it will not leave London Stock Exchange. The company will list on the New York Stock Exchange, moving ...

AstraZeneca, the No. 1 pharmaceutical company in the United Kingdom, said on the 29th (local time) that it plans to directly list on the New York Stock Exchange (NYSE) in February next year.

The Board of AstraZeneca plc (NASDAQ: AZN) is recommending to shareholders a Harmonized Listing Structure for the company's ordinary shares across the London Stock Exchange (LSE), Nasdaq Stockholm ...

To move away from ADRs for direct listing of shares on NYSE To retain UK listing and headquarters North American investors about 22% of shareholder base-LSEG data US is also company's biggest market ...

AstraZeneca, the UK’s second-most valuable company, announced plans Monday to directly list shares in New York, reflecting the growing appeal of US markets for foreign firms. It also sets a worrying ...

AstraZeneca AZN-Q laid out plans on Monday to directly list its shares in the United States, as the drugmaker seeks to maximize gains from its biggest market and investor pool, even as it said that it ...

The move comes after reports that the Anglo-Swedish drugmaker, which is London's most valuable company, was considering ditching its London listing in favour of the U.S. AstraZeneca said on Monday it ...

AstraZeneca plans to directly list its shares on the New York Stock Exchange, instead of its current depositary receipts structure, to attract more global investors, the drugmaker said on Monday, but ...

Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space Get ahead of regulatory and technological ...